Slate Path Capital LP

Slate Path Capital LP is listed in filings as 10% Owner at Cyclerion Therapeutics, Inc.. This profile follows SEC Form 4 activity through Nov 25, 2024, including sale activity. Recent filings connect the profile to Cyclerion Therapeutics, Inc. (CYCN). The current snapshot covers public activity from Nov 25, 2024. Reported amounts are shown as $555.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.